ArticleCancer diagnosis & prognosis
Robust Logistic Regression-based Diagnosis Method of Prostate Cancer Using Optimized Feature Selection on Race Specific Gene-expression Datasets.
Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Optimized Prostate Cancer Stage Classification Using XGBoost Based on Racial miRNA Expression.Cancer diagnosis & prognosisArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: Prostate cancer (PCa) incidence varies significantly by race, with Black men experiencing nearly 1.8 times higher prevalence than White men in the USA. Current prostate specific antigen (PSA)-based diagnostics lack specificity, and many machine learning models fail to consider racial differences in gene expression. This study proposes a race-aware PCa detection framework using optimized feature selection to improve diagnostic accuracy and fairness. Materials and Methods: RNAseq-Count-STAR and clinical phenotype data from TCGA (554 patients) were analyzed. A feature selection pipeline integrating Differential Gene Expression analysis, Receiving Operating Characteristic (ROC) analysis, and Gene-Set Enrichment Analysis identified a 9-gene subset strongly associated with the PCa clinical pathway. The model was trained on White population data and validated on the Black population dataset using various data balancing techniques. Results: The 9-gene logistic regression model achieved 95% accuracy in the White population and 96.8% accuracy in the Black population. Fairness analysis indicated minimal disparity between groups (4% difference in demographic parity, Conclusion: This study introduces a race-specific PCa detection framework that improves diagnostic accuracy using targeted biomarkers. It addresses misclassification risks in race-agnostic models and emphasizes the need for race-aware gene expression in ML diagnostics. Beyond detection, it enables personalized treatment, advancing precision medicine in PCa care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.